Translate page

× To share and enhance best practice management of CML, experts and interested clinicians can discuss difficult or interesting CML cases here. Physicians submit a brief history of the patient and the case for discussion (no more than 200 words) by posting it in this forum ("New Discussion" button below). Please include the country of origin.

Each clinical case will be forwarded to the expert clinical panel for a brief independent response. Consideration should be given to patient confidentiality. Details that are not critical to the case can be changed to preserve anonymity. Please consider including your email with the case. This will not be posted on the website, but is useful should further details be requested by the moderator.

As a full clinical history is necessary for accurate comment, cases and comments on the Forum are ONLY ACCEPTED FROM PHYSICIANS. If individual patients have a specific question we encourage them to contact their healthcare provider. General questions can be emailed to info@cml-foundation.org.

DISCLAIMER: The iCMLf does not recommend or endorse any specific tests, physicians, products, procedures, or opinions, and disclaims any representation, warranty, or guaranty as to the same. Reliance on any information provided in this Forum is solely at your own risk.

A 19 yo on asciminib as 4L, new updates

  • Acy Quixada
  • Acy Quixada's Avatar Topic Author
3 months 2 weeks ago #1954 by Acy Quixada
Replied by Acy Quixada on topic A 19 yo on asciminib as 4L, new updates
Dear Nobuko,

Your teenager patient was initially diagnosed in 2017.

If no information about the correct use of the medication had been given, I would think of poor adherence. This transcript curve resembles poor compliance usually seen in the AYA population, with ups and downs.

With these thoughts. I would consider BMT.

Best regards,
Acy Quixada (Brazil)
Moderators: Nicolaarlene